{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:10:13Z","timestamp":1761675013463},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.ygyno.2003.10.054","type":"journal-article","created":{"date-parts":[[2003,12,19]],"date-time":"2003-12-19T10:58:32Z","timestamp":1071831512000},"page":"537-544","source":"Crossref","is-referenced-by-count":17,"title":["Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions"],"prefix":"10.1016","volume":"92","author":[{"given":"Gabriella","family":"Ferrandina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco Oreste","family":"Ranelletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanda","family":"Salutari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Gessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Legge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Franco","family":"Zannoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libero","family":"Lauriola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2003.10.054_BIB1","series-title":"Cancer: Principles and Practice of Oncology","first-page":"1526","article-title":"Cancer of the cervix, vagina, and vulva","author":"Eifel","year":"2001"},{"key":"10.1016\/j.ygyno.2003.10.054_BIB2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00004347-200101000-00003","article-title":"Vulvar intraepithelial neoplasia: historical aspects and current status","volume":"20","author":"Hart","year":"2001","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB3","first-page":"393","article-title":"Prostaglandins endoperoxide synthase: why two isoforms?","volume":"270","author":"Williams","year":"1996","journal-title":"Am. J. Physiol."},{"issue":"21","key":"10.1016\/j.ygyno.2003.10.054_BIB4","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.ygyno.2003.10.054_BIB5","doi-asserted-by":"crossref","first-page":"13371","DOI":"10.1073\/pnas.222543099","article-title":"Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?","volume":"99","author":"Warner","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB6","first-page":"5767","article-title":"Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells","volume":"60","author":"Souza","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB7","first-page":"6323","article-title":"Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells","volume":"62","author":"Sun","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB8","first-page":"625","article-title":"Cyclooxygenase-2 inhibition by Celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo","volume":"62","author":"Lehay","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5347(05)67321-1","article-title":"Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo","volume":"164","author":"Liu","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4049\/jimmunol.164.1.361","article-title":"Specific inhibition of cyclooxygenase-2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis","volume":"164","author":"Stolina","year":"2000","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.ygyno.2003.10.054_BIB11","first-page":"632","article-title":"Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer","volume":"62","author":"Ristimaki","year":"2002","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2003.10.054_BIB12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1054\/bjoc.2000.1270","article-title":"Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially haematogenous metastasis of colorectal cancer","volume":"83","author":"Tomozawa","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2003.10.054_BIB13","first-page":"861","article-title":"Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer","volume":"7","author":"Khuri","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB14","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1097-0142(20010515)91:10<1876::AID-CNCR1209>3.0.CO;2-H","article-title":"Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma","volume":"91","author":"Ohno","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2003.10.054_BIB15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1200\/JCO.20.4.973","article-title":"Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and poor survival in cervical cancer patients","volume":"20","author":"Ferrandina","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2003.10.054_BIB16","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.bjc.6600578","article-title":"Expression of cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer: clinical implications","volume":"87","author":"Ferrandina","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2003.10.054_BIB17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0360-3016(02)03799-9","article-title":"Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery","volume":"55","author":"Ferrandina","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.ygyno.2003.10.054_BIB18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/annonc\/mdf207","article-title":"Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients","volume":"13","author":"Ferrandina","year":"2002","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2003.10.054_BIB19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/gyno.2002.6620","article-title":"Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR) and Her-2\/neu expression in ovarian cancer","volume":"85","author":"Ferrandina","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2003.10.054_BIB20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/cncr.10736","article-title":"Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome","volume":"95","author":"Ferrandina","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2003.10.054_BIB21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/1097-0215(20011120)95:6<343::AID-IJC1060>3.0.CO;2-D","article-title":"Prognostic significance of cyclooxygenase-2 expression in laryngeal squamous cell carcinoma","volume":"95","author":"Ranelletti","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2003.10.054_BIB22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/carcin\/19.5.723","article-title":"COX-2 expression is induced by UVB in human skin: implications for the development of skin cancer","volume":"19","author":"Buckman","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2003.10.054_BIB23","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<648::AID-IJC6>3.0.CO;2-D","article-title":"Prostaglandin-H-synthase isozyme expression in normal and neoplastic skin","volume":"82","author":"Muller-Decker","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2003.10.054_BIB24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81988-1","article-title":"Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase-2","volume":"87","author":"Oshima","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2003.10.054_BIB25","series-title":"Cyclooxygenase-2 expression in normal cervical epithelium and cervical neoplasia","author":"Sukumvanich","year":"2001"},{"key":"10.1016\/j.ygyno.2003.10.054_BIB26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mc.2940120106","article-title":"Differential expression of prostaglandin H synthase isoenzymes during multistage carcinogenesis in mouse epidermis","volume":"12","author":"Muller-Decker","year":"1995","journal-title":"Mol. Carcinog."},{"issue":"2","key":"10.1016\/j.ygyno.2003.10.054_BIB27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/107327480200902S04","article-title":"Celecoxib, a specific COX-2 inhibitor with anticancer properties","volume":"9","author":"Koki","year":"2002","journal-title":"Cancer Control"},{"key":"10.1016\/j.ygyno.2003.10.054_BIB28","first-page":"3385","article-title":"Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer","volume":"7","author":"Bing","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB29","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/path.992","article-title":"Expression of cyclooxygenase isoforms in normal human skin and chronic venous ulcers","volume":"195","author":"Abd-el-aleem","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB30","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI9621","article-title":"Host cyclooxygenase-2 modulates carcinoma growth","volume":"105","author":"Williams","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB31","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1073\/pnas.94.7.3336","article-title":"Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential","volume":"94","author":"Tsujii","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ygyno.2003.10.054_BIB32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.neo.7900127","article-title":"Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis","volume":"3","author":"Gallo","year":"2001","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.ygyno.2003.10.054_BIB33","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B","article-title":"COX-2 is expressed in human pulmonary, colonic, and mammary tumors","volume":"15;89","author":"Soslow","year":"2000","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2003.10.054_BIB34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0196-0709(95)90040-3","article-title":"Prognostic significance of keratinization in nasopharyngeal carcinoma","volume":"16","author":"Reddy","year":"1995","journal-title":"Am. J. Otolaryngol."},{"issue":"3","key":"10.1016\/j.ygyno.2003.10.054_BIB35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1442-2050.2000.00110.x","article-title":"Assessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in response to preoperative chemotherapy for esophageal squamous cell carcinoma","volume":"13","author":"Szumilo","year":"2000","journal-title":"Dis. Esophagus"},{"issue":"2","key":"10.1016\/j.ygyno.2003.10.054_BIB36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/gyno.1994.1028","article-title":"Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance","volume":"52","author":"Ansink","year":"1994","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2003.10.054_BIB37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0029-7844(95)00045-S","article-title":"Prognostic significance of human papillomavirus DNA in vulvar carcinoma","volume":"85","author":"Monk","year":"1995","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2003.10.054_BIB38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0090-8258(90)90298-Y","article-title":"Risk factors for the development of lymph node metastasis in vulvar squamous cell carcinoma","volume":"37","author":"Binder","year":"1990","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2003.10.054_BIB39","first-page":"3395","article-title":"Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis","volume":"62","author":"Tiano","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/gyno.2000.5739","article-title":"Allelic imbalance in lichen sclerosus, hyperplasia and intraepithelial neoplasia of the vulva","volume":"77","author":"Pinto","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB41","first-page":"315","article-title":"Monoclonal origin of vulvar intraepithelial neoplasia","volume":"150","author":"Tate","year":"1997","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB42","first-page":"1313","article-title":"Patterns of allelic loss (LOH) in vulvar squamous carcinomas and adjacent non invasive epithelia","volume":"152","author":"Lin","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2003.10.054_BIB43","first-page":"545","article-title":"Malignant potential of mixed vulvar dystrophy lichen sclerosus with squamous cell hyperplasia","volume":"33","author":"Rodke","year":"1988","journal-title":"J. Reprod. Med."},{"issue":"9","key":"10.1016\/j.ygyno.2003.10.054_BIB44","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0046-8177(98)90198-8","article-title":"Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case-control and investigational study with historical perspectives; implications for chronic inflammation and sclerosis in the development of neoplasia","volume":"29","author":"Carlson","year":"1998","journal-title":"Human Pathol."},{"issue":"26","key":"10.1016\/j.ygyno.2003.10.054_BIB45","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"N. Engl. J. Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825803007698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825803007698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T03:23:06Z","timestamp":1550287386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825803007698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0090825803007698"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2003.10.054","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}